-
Capital Commentary: 07-04-2026
In a turbulent week for the markets, The Numbers navigated through a series of mixed performances across its portfolio of 12 equities. The overall portfolio experienced a slight loss, underperforming the S&P 500 by 0.19%, posting a total gain/loss of 0.32%. Leading the pack with commendable positive returns was UnitedHealth Group. Our long position in…
-
Capital Commentary: 06-27-2026
In a volatile week of trading, The Numbers portfolio ventured across multiple sectors, yielding mixed results with a net return of -1.68%. This performance, however, edged out the broader market, surpassing the S&P 500, which recorded a dip of 2.07%, by 0.38%. A standout performer was Intel Corporation, whose shares we held long, leading to…
-
Capital Commentary: 06-20-2026
In an impressive performance over the past week, The Numbers’ carefully chosen suite of equity positions has reflected both astute market reading and strategic foresight. A closer look at individual trades provides insight into their stellar performance. Beginning with Texas Instruments, a leading light in the semiconductor industry, The Numbers’ decision to go long paid…
-
Capital Commentary: 06-13-2026
In what proved to be a week of stark contrasts, The Numbers’ portfolio weathered both peaks and valleys, resulting in a narrow overall loss of just 0.06%. This performance lagged slightly behind the S&P 500, which eked out a modest gain of 0.34% during the same period. Of the seven equities traded, just one turning…
-
Capital Commentary: 06-06-2026
In the constantly evolving world of equities, the past week could only be described as a rollercoaster ride for The Numbers’ portfolio. The week offered a mixed bag of results as we navigated the ebbs and flows of market sentiment across a wide span of sectors and geographies. Emerging from the week on a positive…
